ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease

PO Katz, KB Dunbar, FH Schnoll-Sussman… - Official journal of the …, 2022 - journals.lww.com
Gastroesophageal reflux disease (GERD) continues to be among the most common
diseases seen by gastroenterologists, surgeons, and primary care physicians. Our …

Advances in the diagnosis and management of gastroesophageal reflux disease

DA Katzka, PJ Kahrilas - Bmj, 2020 - bmj.com
Gastroesophageal reflux disease (GERD) is a multifaceted disorder encompassing a family
of syndromes attributable to, or exacerbated by, gastroesophageal reflux that impart …

Management of nonvariceal upper gastrointestinal bleeding: guideline recommendations from the International Consensus Group

AN Barkun, M Almadi, EJ Kuipers, L Laine… - Annals of internal …, 2019 - acpjournals.org
Description: This update of the 2010 International Consensus Recommendations on the
Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding (UGIB) refines …

[HTML][HTML] Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified

G Bruno, P Zaccari, G Rocco, G Scalese… - World journal of …, 2019 - ncbi.nlm.nih.gov
Proton pump inhibitors (PPIs) are common medications within the practice of
gastroenterology. These drugs, which act through the irreversible inhibition of the …

The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global …

MA Dirac, S Safiri, D Tsoi, RA Adedoyin… - The Lancet …, 2020 - thelancet.com
Background Gastro-oesophageal reflux disease is a common chronic ailment that causes
uncomfortable symptoms and increases the risk of oesophageal adenocarcinoma. We …

Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies

TN Poly, MM Islam, HC Yang, CC Wu, YCJ Li - Osteoporosis International, 2019 - Springer
We performed a meta-analysis of relevant studies to quantify the magnitude of the
association between proton pump inhibitors (PPIs) and risk of hip fracture. Patients with PPIs …

Surgical treatment of GERD: systematic review and meta-analysis

SK McKinley, RC Dirks, D Walsh, C Hollands… - Surgical …, 2021 - Springer
Background Gastroesophageal reflux disease (GERD) has a high worldwide prevalence in
adults and children. There is uncertainty regarding medical versus surgical therapy and …

Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups

G Gelbenegger, M Postula, L Pecen, S Halvorsen… - BMC medicine, 2019 - Springer
Background The role of aspirin in primary prevention of cardiovascular disease (CVD)
remains unclear. We aimed to investigate the benefit-risk ratio of aspirin for primary …

Education as a low-value improvement intervention: often necessary but rarely sufficient

C Soong, KG Shojania - BMJ quality & safety, 2020 - qualitysafety.bmj.com
Since the launch of Choosing Wisely in the United States, 1 efforts to raise awareness about
avoiding low-value care have spread internationally, 2 prompting numerous commentaries …

Umbrella review of 42 systematic reviews with meta‐analyses: the safety of proton pump inhibitors

EM Salvo, NC Ferko, SB Cash… - Alimentary …, 2021 - Wiley Online Library
Summary Background Proton pump inhibitors (PPIs) are widely used to treat and prevent
acid‐related disorders. Despite high efficacy, PPI safety has been increasingly scrutinised …